Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua C Cyktor

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Frontiers in Cellular and Infection Microbiology|February 28, 2022
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed PatientsGeoffrey T Ivison, Elena Vendrame, Giovanny J Martínez-Colón, et al.
Plos Pathogens|September 21, 2017
T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapyAllison S Thomas, Kimberley L Jones, Rajesh T Gandhi, et al.
The Journal of Clinical Investigation|October 5, 2020
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virusElias K Halvas, Kevin W Joseph, Leah D Brandt, et al.
The Journal of Clinical Investigation|July 31, 2019
HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapyWilliam R McManus, Michael J Bale, Jonathan Spindler, et al.
JCI Insight|August 15, 2023
The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cellsDennis C Copertino, Carissa S Holmberg, Jared Weiler, et al.
JCI Insight|January 5, 2021
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapyEva M Stevenson, Adam R Ward, Ronald Truong, et al.
AIDS (London, England)|March 15, 2024
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trialTrevor A Crowell, Justin Ritz, Lu Zheng, et al.
AIDS (London, England)|December 5, 2023
The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapyJeffrey M Jacobson, Barbara K Felber, Huichao Chen, et al.
The Journal of Clinical Investigation|May 5, 2026
MVA.tHIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapyCynthia L Gay, Yinyan Xu, Ann Marie K Weideman, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Frontiers in Cellular and Infection Microbiology|February 28, 2022
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed PatientsGeoffrey T Ivison, Elena Vendrame, Giovanny J Martínez-Colón, et al.
Plos Pathogens|September 21, 2017
T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapyAllison S Thomas, Kimberley L Jones, Rajesh T Gandhi, et al.
The Journal of Clinical Investigation|October 5, 2020
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virusElias K Halvas, Kevin W Joseph, Leah D Brandt, et al.
The Journal of Clinical Investigation|July 31, 2019
HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapyWilliam R McManus, Michael J Bale, Jonathan Spindler, et al.
JCI Insight|August 15, 2023
The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cellsDennis C Copertino, Carissa S Holmberg, Jared Weiler, et al.
JCI Insight|January 5, 2021
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapyEva M Stevenson, Adam R Ward, Ronald Truong, et al.
AIDS (London, England)|March 15, 2024
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trialTrevor A Crowell, Justin Ritz, Lu Zheng, et al.
AIDS (London, England)|December 5, 2023
The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapyJeffrey M Jacobson, Barbara K Felber, Huichao Chen, et al.
The Journal of Clinical Investigation|May 5, 2026
MVA.tHIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapyCynthia L Gay, Yinyan Xu, Ann Marie K Weideman, et al.
Pageof 4